I do believe that the bulk of the EVDR sales will come from Visisys technology versus the robotics technology. My reasoning for this is that EVDR lacks the capital to build  specific medical robotics without orders for it. Too expensive for them to do that. The visisys technology would not be nearly as cost prohibitive, and would not be as diverse as what the medical robotics industry is.

I do wish EVDR would unveil a marketing format, which would show at least they have a clue on how to run a business. Personally the longer we go along here the more skeptical I am of EVDR's top shelf management. Looks more like another MMG scam to me, again hope I am wrong. Really pathetic how things have progressed since the mergers.